Find Vorozole manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Synopsis

ACTIVE PHARMA INGREDIENTS

0

CEP/COS

CEP/COS Certifications

0

JDMF

JDMFs Filed

0

EU WC

EU WC

0

KDMF

KDMF

0

NDC API

NDC API

0

VMF

NDC API

0

Listed Suppliers

Other Suppliers

API REF. PRICE (USD/KG)

$
$ 0

MARKET PLACE

0

API

0

FDF

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

0

FDF Dossiers

FDF Dossiers

0

FDA Orange Book

FDA (Orange Book)

0

Europe

Europe

0

Canada

Canada

0

Australia

Australia

0

South Africa

South Africa

0

Listed Dossiers

Listed Dossiers

0 DRUGS IN DEVELOPMENT

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

0

EDQM

0

USP

0

JP

0

Others

PATENTS & EXCLUSIVITIES

0

US Patents

0

US Exclusivities

0

Health Canada Patents

DIGITAL CONTENT

0

Data Compilation #PharmaFlow

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

0

News #PharmaBuzz

GLOBAL SALES INFORMATION

US Medicaid

NA

Annual Reports

NA

Finished Drug Prices

NA

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: Vorozole, 129731-10-8, R-83842, 1e2s9yxv2a, R 83842, 6-[(s)-(4-chlorophenyl)-(1,2,4-triazol-1-yl)methyl]-1-methylbenzotriazole
Molecular Formula
C16H13ClN6
Molecular Weight
324.77  g/mol
InChI Key
XLMPPFTZALNBFS-INIZCTEOSA-N
FDA UNII
1E2S9YXV2A

Vorozole
1 2D Structure

Vorozole

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
6-[(S)-(4-chlorophenyl)-(1,2,4-triazol-1-yl)methyl]-1-methylbenzotriazole
2.1.2 InChI
InChI=1S/C16H13ClN6/c1-22-15-8-12(4-7-14(15)20-21-22)16(23-10-18-9-19-23)11-2-5-13(17)6-3-11/h2-10,16H,1H3/t16-/m0/s1
2.1.3 InChI Key
XLMPPFTZALNBFS-INIZCTEOSA-N
2.1.4 Canonical SMILES
CN1C2=C(C=CC(=C2)C(C3=CC=C(C=C3)Cl)N4C=NC=N4)N=N1
2.1.5 Isomeric SMILES
CN1C2=C(C=CC(=C2)[C@H](C3=CC=C(C=C3)Cl)N4C=NC=N4)N=N1
2.2 Other Identifiers
2.2.1 UNII
1E2S9YXV2A
2.3 Synonyms
2.3.1 MeSH Synonyms

1. (n-methyl-(11c))vorozole

2. 6-((4-chlorophenyl)-(1h-1,2,4-triazol-1-yl)methyl)-1-methyl-1h-benzotriazole

3. R 76713

4. R 83839

5. R 83842

6. R-76713

7. R-83839

8. R-83842

9. Vorozole

10. Vorozole, (+)-isomer

2.3.2 Depositor-Supplied Synonyms

1. Vorozole

2. 129731-10-8

3. R-83842

4. 1e2s9yxv2a

5. R 83842

6. 6-[(s)-(4-chlorophenyl)-(1,2,4-triazol-1-yl)methyl]-1-methylbenzotriazole

7. Vorozolum

8. Vorozol

9. 1h-benzotriazole, 6-((4-chlorophenyl)-1h-1,2,4-triazol-1-ylmethyl)-1-methyl-, (s)-

10. (s)-6-((4-chlorophenyl)(1h-1,2,4-triazol-1-yl)methyl)-1-methyl-1h-benzo[d][1,2,3]triazole

11. Vorozol [inn-spanish]

12. Vorozolum [inn-latin]

13. Unii-1e2s9yxv2a

14. Vorozole [usan:inn:ban]

15. Ccris 7482

16. Rivizor (tn)

17. Vorozole [usan]

18. Vorozole (usan/inn)

19. Vorozole [inn]

20. Vorozole [mi]

21. (s)-vorozole

22. Vorozole [mart.]

23. Vorozole [who-dd]

24. Schembl4554

25. Chembl224060

26. Dtxsid20156230

27. Chebi:135387

28. Bcp04202

29. Zinc3791538

30. Bdbm50378780

31. Db13767

32. (+)-(s)-6-(p-chloro-alpha-1h-1,2,4-triazol-1-ylbenzyl)-1-methyl-1h-benzotriazole

33. R76713

34. Hy-19599

35. Bcp0726000088

36. Cs-0015881

37. D03786

38. R-83942

39. Q7941876

40. (+)-(s)-6-(p-chloro-a-1h-1,2,4-triazol-1-ylbenzyl)-1-methyl-1h-benzotriazole

41. (+)-6-[(4-chlorophenyl)(1h-1,2,4-triazol-1-yl)methyl]-1-methyl-1h- Benzotriazole

42. (s)-6-[(4-chlorophenyl)-(1,2,4-triazol-1-yl)methyl]-1-methylbenzotriazole

43. 1-methyl-6-[(s)-alpha-(1h-1,2,4-triazol-1-yl)-4-chlorobenzyl]-1h-benzotriazole

2.4 Create Date
2006-07-28
3 Chemical and Physical Properties
Molecular Weight 324.77 g/mol
Molecular Formula C16H13ClN6
XLogP33.1
Hydrogen Bond Donor Count0
Hydrogen Bond Acceptor Count4
Rotatable Bond Count3
Exact Mass324.0890221 g/mol
Monoisotopic Mass324.0890221 g/mol
Topological Polar Surface Area61.4 Ų
Heavy Atom Count23
Formal Charge0
Complexity402
Isotope Atom Count0
Defined Atom Stereocenter Count1
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
4 Pharmacology and Biochemistry
4.1 MeSH Pharmacological Classification

Antineoplastic Agents

Substances that inhibit or prevent the proliferation of NEOPLASMS. (See all compounds classified as Antineoplastic Agents.)


Aromatase Inhibitors

Compounds that inhibit AROMATASE in order to reduce production of estrogenic steroid hormones. (See all compounds classified as Aromatase Inhibitors.)


4.2 ATC Code

L - Antineoplastic and immunomodulating agents

L02 - Endocrine therapy

L02B - Hormone antagonists and related agents

L02BG - Aromatase inhibitors

L02BG05 - Vorozole


ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty